Benzinga's Top Upgrades, Downgrades For June 29, 2020

Upgrades

• SunTrust Robinson Humphrey changed the rating for CoreLogic Inc CLGX from Hold to Buy. In the first quarter, CoreLogic showed an EPS of $0.76, compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $68.40 and a 52-week-low of $24.69. CoreLogic's stock last closed at $67.95 per share.
• For Big Lots Inc BIG, Loop Capital upgraded the stock from Hold to Buy. For the first quarter, Big Lots had an EPS of $1.26, compared to year-ago quarter EPS of $0.92. The stock has a 52-week-high of $44.90 and a 52-week-low of $10.12. Big Lots's stock last closed at $43.02 per share.
• For Southwest Airlines Co LUV, Goldman Sachs upgraded the stock from Sell to Buy. For the first quarter, Southwest Airlines had an EPS of ($0.15), compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of $58.83 and a 52-week-low of $22.46. Southwest Airlines's stock last closed at $31.96 per share.
• Raymond James upgraded the stock for CDW Corp CDW from Market Perform to Outperform. In the first quarter, CDW showed an EPS of $1.38, compared to $1.24 from the year-ago quarter. The stock has a 52-week-high of $146.09 and a 52-week-low of $73.39. CDW's stock last closed at $108.49 per share.
• Evercore ISI Group changed the rating for Chart Industries Inc GTLS from In-Line to Outperform. In the first quarter, Chart Industries showed an EPS of $0.57, compared to $0.39 from the year-ago quarter. The stock has a 52-week-high of $78.80 and a 52-week-low of $15.00. Chart Industries's stock last closed at $45.22 per share.
• For The Middleby Corp MIDD, KeyBanc upgraded the stock from Sector Weight to Overweight. The Middleby earned $1.33 in the first quarter, compared to $1.38 in the year-ago quarter. The stock has a 52-week-high of $142.98 and a 52-week-low of $41.73. The Middleby's stock last closed at $72.98 per share.

Downgrades

• Credit Suisse changed the rating for AMC Entertainment Holdings Inc AMC from Neutral to Underperform. For the first quarter, AMC Entertainment had an EPS of ($2.22), compared to year-ago quarter EPS of ($1.25). The stock has a 52-week-high of $12.49 and a 52-week-low of $1.95. AMC Entertainment's stock last closed at $4.16 per share.
• For Beyond Meat Inc BYND, Barclays downgraded the stock from Overweight to Underweight. Beyond Meat earned $0.03 in the first quarter, compared to ($0.14) in the year-ago quarter. The stock has a 52-week-high of $239.71 and a 52-week-low of $48.18. Beyond Meat's stock last closed at $141.68 per share.
• For Cinemark Holdings Inc CNK, Credit Suisse downgraded the stock from Outperform to Neutral. For the first quarter, Cinemark Hldgs had an EPS of ($0.37), compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $41.60 and a 52-week-low of $5.71. Cinemark Hldgs's stock last closed at $11.39 per share.
• Wells Fargo downgraded the stock for CoreLogic Inc CLGX from Overweight to Equal-Weight. CoreLogic earned $0.76 in the first quarter, compared to $0.45 in the year-ago quarter. The stock has a 52-week-high of $68.40 and a 52-week-low of $24.69. CoreLogic's stock last closed at $67.95 per share.
• For Diamondback Energy Inc FANG, BMO Capital downgraded the stock from Outperform to Market Perform. In the first quarter, Diamondback Energy showed an EPS of $1.45, compared to $1.39 from the year-ago quarter. The stock has a 52-week-high of $111.84 and a 52-week-low of $14.55. Diamondback Energy's stock last closed at $41.13 per share.
• For Fiserv Inc FISV, Oppenheimer downgraded the stock from Outperform to Perform. Fiserv earned $0.99 in the first quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $125.05 and a 52-week-low of $73.50. Fiserv's stock last closed at $94.92 per share.
• Goldman Sachs changed the rating for Neurocrine Biosciences Inc NBIX from Buy to Neutral. For the first quarter, Neurocrine Biosciences had an EPS of $0.82, compared to year-ago quarter EPS of ($1.12). The stock has a 52-week-high of $131.00 and a 52-week-low of $72.14. Neurocrine Biosciences's stock last closed at $130.36 per share.
• BMO Capital changed the rating for Pilgrims Pride Corp PPC from Outperform to Market Perform. In the first quarter, Pilgrims Pride showed an EPS of $0.18, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $33.67 and a 52-week-low of $15.75. Pilgrims Pride's stock last closed at $16.69 per share.
• Guggenheim downgraded the stock for Spotify Technology SA SPOT from Neutral to Sell. In the first quarter, Spotify Technology showed an EPS of ($0.22), compared to ($0.90) from the year-ago quarter. The stock has a 52-week-high of $271.71 and a 52-week-low of $109.18. Spotify Technology's stock last closed at $265.05 per share.
• HC Wainwright & Co. downgraded the stock for Inovio Pharmaceuticals Inc INO from Buy to Neutral. For the first quarter, Inovio Pharmaceuticals had an EPS of ($0.26), compared to year-ago quarter EPS of ($0.30). The stock has a 52-week-high of $33.79 and a 52-week-low of $1.92. Inovio Pharmaceuticals's stock last closed at $29.98 per share.

Initiations

• Piper Sandler initiated coverage on Leap Therapeutics Inc LPTX with an Overweight rating. The price target for Leap Therapeutics is set at $6.00. For the first quarter, Leap Therapeutics had an EPS of ($0.55), compared to year-ago quarter EPS of ($0.47). The stock has a 52-week-high of $3.18 and a 52-week-low of $0.57. Leap Therapeutics's stock last closed at $2.19 per share.
• Jefferies initiated coverage on Madison Square Garden Entertainment Corp MSGE with a Buy rating. The price target for Madison Square Garden is set at $100.00. The stock has a 52-week-high of $87.20 and a 52-week-low of $62.50. Madison Square Garden's stock last closed at $72.65 per share.
• HSBC initiated coverage on Otis Worldwide Corp OTIS with a Reduce rating. The price target for Otis Worldwide is set at $44.00. The stock has a 52-week-high of $61.46 and a 52-week-low of $41.26. Otis Worldwide's stock last closed at $55.82 per share.
• Cowen & Co. initiated coverage on Pliant Therapeutics Inc PLRX with an Outperform rating. The stock has a 52-week-high of $31.99 and a 52-week-low of $21.05. Pliant Therapeutics's stock last closed at $31.72 per share.
• JP Morgan initiated coverage on Warner Music Group Corp WMG with an Overweight rating. The price target for Warner Music Group is set at $40.00. The stock has a 52-week-high of $34.76 and a 52-week-low of $26.99. Warner Music Group's stock last closed at $30.47 per share.
• With a rating of Sector Perform, RBC Capital initiated coverage on ZoomInfo Technologies Inc ZI. The price target is set at $50.00 for ZoomInfo Technologies. The stock has a 52-week-high of $64.40 and a 52-week-low of $32.10. ZoomInfo Technologies's stock last closed at $51.57 per share.
• B of A Securities initiated coverage on ZoomInfo Technologies Inc ZI with a Buy rating. The price target for ZoomInfo Technologies is set at $60.00. The stock has a 52-week-high of $64.40 and a 52-week-low of $32.10. ZoomInfo Technologies's stock last closed at $51.57 per share.
• Evercore ISI Group initiated coverage on Warner Music Group Corp WMG with an Outperform rating. The price target for Warner Music Group is set at $36.00. The stock has a 52-week-high of $34.76 and a 52-week-low of $26.99. Warner Music Group's stock last closed at $30.47 per share.
• SVB Leerink initiated coverage on Nuance Communications Inc NUAN with an Outperform rating. The price target for Nuance Communications is set at $31.00. For the second quarter, Nuance Communications had an EPS of $0.21, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $26.01 and a 52-week-low of $13.51. Nuance Communications's stock last closed at $25.39 per share.
• HC Wainwright & Co. initiated coverage on Arena Pharmaceuticals Inc ARNA with a Buy rating. The price target for Arena Pharmaceuticals is set at $90.00. In the first quarter, Arena Pharmaceuticals showed an EPS of ($2.00), compared to $12.34 from the year-ago quarter. The stock has a 52-week-high of $69.75 and a 52-week-low of $32.95. Arena Pharmaceuticals's stock last closed at $65.92 per share.
• Needham initiated coverage on Enphase Energy Inc ENPH with a Buy rating. The price target for Enphase Energy is set at $53.00. In the first quarter, Enphase Energy showed an EPS of $0.38, compared to $0.08 from the year-ago quarter. The stock has a 52-week-high of $70.36 and a 52-week-low of $16.32. Enphase Energy's stock last closed at $45.30 per share.